Afiveg

Afiveg is an intravitreal injection used to treat eye conditions. It contains aflibercept, a medication that targets vascular growth factors. This product is manufactured by Stada Arzneimittel AG in the EU.

Afiveg is primarily used for the treatment of eye conditions related to abnormal blood vessel growth. It is often prescribed for conditions like wet age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion. Aflibercept, the active ingredient, works by inhibiting vascular endothelial growth factor (VEGF), which helps to reduce abnormal blood vessel growth in the eye.

Common effects of Afiveg may include temporary vision disturbances, eye redness, and discomfort at the injection site. Some users may also experience floaters or increased eye pressure. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Afiveg should be handled with care and administered by a healthcare professional. It is important to follow all instructions provided by your healthcare provider. Do not use Afiveg if you are allergic to aflibercept or any of its components. Inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Afiveg may interact with other medications, particularly those that affect the immune system or blood vessels. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with Afiveg, so it is advisable to discuss your diet and lifestyle with your healthcare provider.